查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1864098

按类型、应用程式、最终用户、分销管道、软体类型和工作流程类型分類的自动化配药设备市场—全球预测，2025-2032年

Automated Compounding Devices Market by Type, Application, End User, Distribution Channel, Software Type, Workflow Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，自动配药设备市场规模将达到 58.5 亿美元，复合年增长率为 10.86%。

关键市场统计数据
基准年 2024 25.6亿美元
预计年份：2025年 28.4亿美元
预测年份 2032 58.5亿美元
复合年增长率 (%) 10.86%

一份针对医疗保健决策者的简明指南，内容涵盖自动化配药设备的作用、营运重点、安全预期和整合注意事项。

在现代无菌配药流程中，自动化配药设备扮演着日益重要的角色，精准性、可重复性和安全性在此交会融合，以满足严苛的临床需求。此技术领域涵盖多种机械结构和软体层，旨在减少人为操作的差异，提高剂量准确性，并降低污染风险。这些系统在药房运营、临床管治和供应链管理的交汇点发挥着战略性作用，并已广泛应用于包括急诊机构、零售药房、专科药房和家庭输液项目在内的各种场所。

临床复杂性、人力资源限制、日益严格的监管以及软体主导的整合如何重塑药房的采购重点和营运模式

由于临床复杂性日益增加、人员短缺以及对无菌配药流程监管日益严格等因素，自动化配药领域正在经历变革。先进的肿瘤治疗方法和不断扩大的生物製药产品组合要求配药系统能够容纳日益多样化的药物类别，同时保持严格的隔离和无菌标准。同时，人手不足以及将训练有素的药房人员重新部署到临床工作的需要，加速了人们对自动化的兴趣，以减轻人工配药的负担，并最大限度地减少高风险任务中的认知负荷。

2025年关税调整对医疗设备筹资策略、供应商谈判趋势及生命週期成本考量的影响

2025年美国实施的关税政策调整和贸易措施对自动化配药设备的筹资策略、供应商选择和总体拥有成本产生了实际的影响。某些进口医疗设备和组件关税的提高促使医疗机构和经销商重新评估其采购方案，一些机构加快了转向国内製造的替代品和区域供应商的步伐，以降低关税风险。由于买家寻求保护其营运免受供应链中断和成本上升的影响，这些变化正在影响有关长期服务合约、备件库存政策和保固条款的谈判。

将设备类型、临床应用案例、最终用户环境、通路、软体模型和工作流程模式与采购逻辑联繫起来的综合細項分析

细緻的细分框架揭示了设备选择和实施优先顺序如何因技术类型、临床应用、使用者环境、分销管道、软体架构和工作流程模式而异。依类型将设备分类时，蠕动式、活塞式和容积式结构各有其独特的优点。蠕动式设计通常适用于封闭系统和污染控制模式。活塞式系统可实现对黏稠或黏度可变的製剂的高精度计量。容积式解决方案通常用于高通量液体处理任务。这些技术差异会根据治疗和操作需求转化为不同的适用性。

美洲、欧洲、中东和非洲以及亚太地区医疗保健市场的区域趋势和采用驱动因素正在影响采购选择、合规要求和服务模式。

在全球范围内，区域趋势对采用模式、监管重点和供应商策略有显着影响。在美洲，先进的医院基础设施、不断扩大的门诊输液市场以及肿瘤和专科药房等卓越医疗中心的集中分布正在塑造市场需求。这种环境有利于那些符合严格的当地监管标准并与电子健康记录和条码检验系统紧密整合的解决方案。此外，大规模综合医疗网络倾向于寻求能够提供集中支援和跨多个机构标准化工作流程的供应商伙伴关係。

竞争优势主要体现在整合解决方案、检验的工作流程、区域覆盖范围以及满足临床和营运需求的创新蓝图等方面。

在自动化药局领域，竞争日益取决于能否提供端到端的解决方案，这些方案需要结合强大的硬体和可互通的软体、响应迅速的服务网路以及检验的工作流程套件。主要企业透过投资人体工学、危险药物防护技术以及强大的互通性框架来脱颖而出，这些框架能够实现与药房资讯系统和电子健康记录的安全资料交换。此外，能够提供全面的检验支援、用户培训计划和可预测的维护服务合同，也能增强供应商在先进医疗系统采购商中的信誉。

这是一份实用的采购和实施指南，旨在帮助领导者确保系统检验，增强服务连续性，并实现自动化带来的临床和营运效益。

产业领导者应采取策略性方法，使采购决策与临床管治目标、营运实际情况和长期服务韧性保持一致。首先，应成立一个跨职能审查委员会，成员包括药房领导、感染控制、医疗设备管理和采购部门，以确保设备选择能够体现临床、安全和技术方面的优先事项。该委员会应制定客观标准，考虑防护能力、互通性、检验支援和本地服务可用性。

调查方法结合了针对性强的相关人员访谈、法规和标准审查以及供应商检验资料，以确保获得可靠且具有行动导向的洞见。

本执行摘要的研究综合分析采用三角测量法构建，结合了对临床药学负责人、医疗设备工程师和分销合作伙伴的访谈、对无菌配製相关监管指南和标准的二次分析，以及对供应商技术文献和产品检验材料的系统性回顾。主要研究旨在探索从大型三级医院到社区药局等各种类型机构在实际运作中面临的挑战、所需功能和服务期望。

将自动化定位为程序性投资，并整合相关策略需求：这需要管治、互通性和持续的绩效管理。

在适当的管治和支援下，自动化分发设备能够显着提高准确性、安全性和营运扩充性，使其成为现代无菌製剂策略的重要组成部分。设备架构、软体功能和最终用户环境之间的相互作用决定了自动化在多大程度上能够带来临床和营运价值。因此，采购决策应基于整体观点，综合考量技术适用性、法规遵循、供应商可维护性和人员准备。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧整合到无菌配製工作流程中，以实现预测性维护和流程优化
  • 扩展机器人配药系统并引入条码检验，可减少人为错误并加强病患安全措施。
  • 开发一种整合到药房自动化系统中的封闭式传输装置，用于危险药物处理合规性检查。
  • 实施云端基础的软体平台，用于远端监控药房营运和即时数据分析
  • 适用于高风险化疗和生物製药的可客製化分装模组，具备在线连续重量检验
  • 转向采用模组化、扩充性的配药单元，专为医院药房的照护现场应用而设计
  • 引入一次性产品和单次使用无菌盒，以简化清洁验证流程并降低交叉污染的风险
  • 药房设备製造商与电子病历供应商合作，实现从处方到生产的无缝工作流程
  • 监管审查力度加大，推动了符合 ISO 5 标准且具有自动环境监测功能的分配外壳的普及。
  • 利用网路化自动化技术满足个人化医疗需求的去中心化药局中心正在兴起。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按类型分類的自动配药设备市场

  • 蠕动型
  • 活塞驱动型
  • 正位移

第九章 按应用分類的自动点胶设备市场

  • 缓解疼痛
  • 化疗
    • 普通肿瘤科
    • 标靶治疗
  • 静脉营养
    • 中央静脉
    • 週边静脉

第十章 以最终用户分類的自动配药设备市场

  • 配药药房
  • 居家医疗
  • 医院药房
    • 大型医院
    • 小规模医院
  • 零售药房

第十一章：按通路分類的自动配药设备市场

  • 直销
  • 经销商
    • 全国经销商
    • 区域经销商
  • 线上销售

第十二章：以软体类型分類的自动配药设备市场

  • 融合的
  • 独立版

第十三章：依工作流程类型分類的自动化配药设备市场

  • 批次
  • 连续型

第十四章 各地区的自动配药设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 依组别分類的自动配药设备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国自动配药设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Baxter International Inc.
    • Fresenius Kabi AG
    • B. Braun Melsungen AG
    • ICU Medical, Inc.
    • Omnicell, Inc.
    • Ivenix, Inc.
    • Qcore Medical, Inc.
    • Telstar SA
    • Swisslog AG
    • Capsa Healthcare, Inc.
Product Code: MRR-BB4648AFF305

The Automated Compounding Devices Market is projected to grow by USD 5.85 billion at a CAGR of 10.86% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.56 billion
Estimated Year [2025] USD 2.84 billion
Forecast Year [2032] USD 5.85 billion
CAGR (%) 10.86%

A concise orientation to automated compounding device roles, operational priorities, safety expectations, and integration considerations for healthcare decision-makers

Automated compounding devices are increasingly central to contemporary sterile preparation workflows, where precision, repeatability, and safety converge to meet stringent clinical demands. The technology landscape spans a range of mechanical architectures and software layers designed to reduce manual variability, improve dosing accuracy, and mitigate contamination risks. These systems occupy a strategic role at the intersection of pharmacy operations, clinical governance, and supply chain management, and they are being deployed across acute care settings, retail and specialty compounding pharmacies, and home infusion programs.

As decision-makers consider investments in automated compounding solutions, they are balancing clinical imperatives against operational realities: device integration with existing information systems, compatibility with clinical workflows, staff training needs, and the evolving regulatory scrutiny on aseptic processing. Stakeholders are also observing growing emphasis on traceability and auditability, driven by the need to document chain-of-custody for high-risk preparations. Consequently, procurement evaluation extends beyond the hardware to include software interoperability, vendor support models, and lifecycle maintenance commitments.

In this context, understanding device typologies, application domains, and end-user requirements is essential for framing deployment strategies. Technology choices influence throughput, error rates, and the ability to scale services to meet changing demand patterns. Therefore, an informed introduction to automated compounding must highlight the practical trade-offs between device capabilities, workflow fit, and clinical governance obligations to enable responsible, high-value adoption across care settings.

How clinical complexity, workforce constraints, regulatory rigor, and software-driven integration are reshaping procurement priorities and operational models in compounding

The landscape for automated compounding is undergoing transformative shifts driven by clinical complexity, workforce pressures, and heightened regulatory focus on aseptic processing. Advanced oncology regimens and the widening portfolio of biologics require compounding systems that can handle increasingly diverse drug classes while maintaining stringent containment and sterility profiles. At the same time, labor shortages and the need to reallocate highly trained pharmacy staff toward clinical tasks have accelerated interest in automation that reduces manual preparation burden and minimizes cognitive load during high-risk activities.

Recent technology maturation has emphasized modularity and software-driven orchestration, enabling tighter integration with pharmacy information systems and electronic health records. These developments support improved dose verification, barcode-enabled verification, and electronic batch records that together strengthen quality assurance pathways. Parallel to these technological trends, regulatory authorities are intensifying their expectations for process validation, environmental monitoring, and traceability, prompting providers to prioritize systems with robust audit trails and validated workflows.

Operationally, there is a notable move toward solutions that facilitate decentralized compounding and hybrid service models, where centralized sterile production coexists with point-of-care preparation in outpatient and home settings. This shift is accompanied by renewed attention to supply chain resilience and service continuity, encouraging buyers to evaluate vendor ecosystems for spare parts, local service presence, and software update strategies. Taken together, these factors are reshaping procurement criteria and influencing which device architectures and vendor partnerships are most likely to deliver sustainable clinical and commercial value over time.

Implications of 2025 tariff adjustments on sourcing strategies, vendor negotiation dynamics, and lifecycle cost considerations for device procurement

Tariff policy changes and trade measures enacted in the United States in 2025 have introduced tangible implications for procurement strategies, vendor selection, and total cost of ownership for automated compounding devices. In response to increased duties on certain imported medical devices and components, healthcare organizations and distributors reassessed sourcing options, with some accelerating moves toward domestically manufactured alternatives or regional suppliers to mitigate tariff exposure. These shifts have influenced negotiations around long-term service agreements, spare parts stocking policies, and warranty conditions as buyers sought to insulate operations from supply chain disruptions and cost escalations.

Manufacturers with diversified production footprints or established assembly facilities within tariff-advantaged jurisdictions were relatively better positioned, enabling them to preserve competitive pricing for core devices. Conversely, suppliers reliant on single-country manufacturing faced pressure to absorb higher landed costs or to pass them on to customers, prompting discussions about value-based contracting and extended service commitments to justify revised pricing. For health systems, procurement teams increasingly emphasized total lifecycle assessments, capturing not only acquisition price but also ongoing serviceability, lead times for consumables, and the availability of validated software updates.

Looking ahead, purchasers are incorporating tariff risk into supplier scorecards and contingency planning, evaluating options such as multi-sourcing, local assembly partners, and inventory buffering for critical consumables. These pragmatic responses aim to maintain operational continuity while preserving the clinical benefits of automation. In doing so, organizations are refining procurement policies to balance near-term cost fluctuations against long-term clinical and compliance priorities.

Comprehensive segmentation analysis linking device typologies, clinical use-cases, end-user settings, distribution pathways, software models, and workflow modalities to procurement logic

A nuanced segmentation framework reveals how device selection and deployment priorities vary across technical typologies, clinical applications, user settings, distribution channels, software architectures, and workflow modalities. When categorizing devices by type, peristaltic, piston driven, and volumetric architectures present distinct advantages: peristaltic designs are often favored for closed-system, contamination-controlled modalities; piston driven systems can deliver high-precision dosing for viscous or variable-viscosity formulations; and volumetric solutions are commonly selected for high-throughput liquid handling tasks. These technical differences translate into differential suitability depending on therapeutic and operational needs.

Application-focused segmentation further refines purchasing logic, especially where oncology creates special requirements for containment and hazardous drug handling. Analgesia preparations emphasize dose personalization and rapid turnaround, whereas chemotherapy compounding necessitates secure containment and strict environmental control; within chemotherapy, general oncology regimens and targeted therapies impose divergent requirements for preparation complexity and dose verification. Parenteral nutrition introduces another layer of complexity, where central venous and peripheral venous formulations demand differing volumetric accuracy and compatibility with multi-component mixing protocols.

End-user context shapes operational priorities as well. Compounding pharmacies often prioritize throughput and regulatory documentation; home healthcare services emphasize portability and simplified user interfaces for community nurses; hospital pharmacies need devices that integrate with large electronic ecosystems and accommodate both large hospital and small hospital workflows, each with varying staffing models and physical spaces. Distribution channel dynamics influence access and support models, with direct sales offering close vendor alignment, distributors-whether national or regional-providing reach and aftersales networks, and online sales facilitating transactional procurement for consumables and peripheral software licenses. Software architecture choices between integrated and standalone systems determine how tightly device controls and batch records can be woven into broader pharmacy information systems. Lastly, workflow typologies such as batch and continuous processing define throughput planning and the degree of human oversight required, shaping the physical layout and staffing models around compounding operations. Altogether, this segmentation perspective helps align technical capability with clinical need and operational reality.

Regional dynamics and adoption drivers that shape procurement choices, compliance expectations, and service models across Americas, EMEA, and Asia-Pacific healthcare markets

Regional dynamics exert a material influence on adoption patterns, regulatory priorities, and vendor strategies across the global landscape. In the Americas, demand is shaped by a combination of advanced hospital infrastructure, a growing outpatient infusion market, and concentrated centers of excellence in oncology and specialty pharmacy. This environment favors solutions that demonstrate compliance with rigorous local regulatory standards and that integrate tightly with electronic health records and barcode verification systems. Moreover, large integrated delivery networks often seek vendor partnerships that provide centralized support and standardized workflows across multiple facilities.

In Europe, the Middle East & Africa, regulatory harmonization across certain jurisdictions coexists with notable variations in procurement practices and reimbursement pressures. Providers tend to prioritize clinical safety and environmental controls, while procurement teams evaluate total cost of ownership and service availability across heterogeneous healthcare delivery systems. Regional distributors and localized service organizations play a pivotal role in bridging multinational vendor offerings with local compliance needs and training requirements.

The Asia-Pacific region is characterized by a mix of advanced urban centers with high adoption potential and emerging markets where incremental automation is gaining traction as healthcare capacity expands. In mature urban healthcare systems, integration with hospital information technology and support for high-throughput oncology centers drive demand for robust automation platforms. Meanwhile, in other regional markets, buyers are focused on scalable solutions that balance upfront affordability with modular upgrade paths, enabling phased adoption as clinical volumes and technical capabilities mature. Across all regions, considerations such as local manufacturing, aftersales support footprint, and the availability of regulatory-compliant consumables materially influence vendor competitiveness and adoption velocity.

Competitive differentiators centered on integrated solutions, validated workflows, regional service strength, and innovation roadmaps that address clinical and operational needs

Competitive positioning in the automated compounding space is increasingly influenced by the ability to deliver end-to-end solutions that combine robust hardware with interoperable software, responsive service networks, and validated workflow packages. Leading firms differentiate through investments in human factors engineering, containment technologies for hazardous drugs, and strong interoperability frameworks that enable secure data exchange with pharmacy information systems and electronic health records. In addition, capability to provide comprehensive validation support, user training programs, and predictable maintenance service contracts strengthens vendor credibility with sophisticated health system buyers.

Partnerships between device manufacturers and software integrators are becoming more commonplace, as stakeholders expect seamless batch record generation, barcode verification, and electronic audit trails. Companies that offer modular systems with configurable options for oncology, analgesia, and parenteral nutrition applications are better positioned to address heterogeneous customer needs. Regional service networks and distributor alliances are critical for ensuring timely spare parts delivery and on-the-ground technical support, particularly in markets with complex regulatory or logistical challenges.

Innovation roadmaps that emphasize cloud-enabled analytics, predictive maintenance, and enhanced user interfaces are emerging as differentiators, but they must be balanced against data security and regulatory compliance requirements. Ultimately, providers that demonstrate a commitment to validated workflows, continuous improvement, and transparent post-sale support tend to earn the trust of pharmacy and clinical leaders tasked with safeguarding sterile preparation quality and operational resilience.

Practical procurement and deployment playbook for leaders to secure validated systems, fortify service continuity, and realize clinical and operational gains from automation

Industry leaders should adopt a strategic approach that aligns procurement decisions with clinical governance objectives, operational realities, and long-term service resilience. First, establish a cross-functional evaluation committee that includes pharmacy leadership, infection control, biomedical engineering, and procurement to ensure that device selection reflects clinical, safety, and technical priorities. This committee should define objective criteria that account for containment capabilities, interoperability, validation support, and local service availability.

Second, prioritize vendors who can demonstrate robust integration with existing enterprise systems and who provide validated workflows for the primary clinical applications of interest. Where tariff risk or supply chain fragility exists, consider contractual protections such as price-stability clauses, local assembly options, or predefined parts consignment arrangements to mitigate operational exposure. Additionally, require clear post-sale service-level agreements with measurable response times and defined spare parts availability, so that uptime expectations are aligned with clinical dependency on compounding outputs.

Third, invest in training and change management to ensure effective adoption. Automation gains are realized only when staff are proficient in device operation, troubleshooting, and in reconciling electronic batch records with clinical documentation. Implement phased rollouts-starting with pilot deployments in controlled settings-before scaling across larger hospital or network environments. Finally, embed continuous improvement processes that capture performance metrics, near-miss events, and user feedback to iteratively refine workflows and vendor partnerships. These actions will help leaders transform technology investments into demonstrable improvements in safety, efficiency, and clinical reliability.

Methodological approach combining targeted stakeholder interviews, regulatory and standards review, and vendor validation materials to ensure robust, practice-oriented insights

The research synthesis underpinning this executive summary was developed through a triangulated methodology combining primary interviews with clinical pharmacy leaders, biomedical engineers, and distribution partners; secondary analysis of regulatory guidance and standards relevant to sterile compounding; and a structured review of vendor technical literature and product validation materials. Primary engagements were designed to explore real-world operational challenges, desired feature sets, and service expectations across a spectrum of facility types, from large tertiary hospitals to community-based compounding pharmacies.

Secondary research focused on regulatory frameworks, standard operating procedures for aseptic processing, and best-practice guidance that informs device validation and environmental monitoring. This contextual analysis provided a lens for assessing how product capabilities align with compliance requirements and clinical safety imperatives. Vendor documentation was examined to understand architectural differences between device types, software interoperability options, and service models, with special attention paid to evidence of validated workflows and traceability features.

Synthesis involved iterative validation, where preliminary findings were reviewed with subject-matter experts to ensure accuracy and relevance. The methodology emphasized transparency and reproducibility, documenting assumptions and evidence chains so that stakeholders can assess the provenance of insights. Collectively, this approach supports robust, practice-oriented conclusions while acknowledging the variability in local practice and regulatory interpretation.

Synthesis of strategic imperatives that frame automation as a programmatic investment requiring governance, interoperability, and continuous performance management

Automated compounding devices are now integral to modern sterile preparation strategies, offering pathways to improved precision, enhanced safety, and operational scalability when deployed with appropriate governance and support. The interplay between device architecture, software capabilities, and end-user context determines the degree to which automation delivers clinical and operational value. Consequently, procurement decisions should be informed by a comprehensive view that integrates technical fit, regulatory compliance, vendor serviceability, and workforce readiness.

The current environment presents both opportunities and complexities: advanced therapies and shifting care delivery models increase the clinical need for reliable compounding solutions, while evolving regulatory expectations and supply chain uncertainties demand vigilant procurement and contract design. Organizations that adopt a disciplined, cross-functional approach to evaluation, prioritize interoperability and validated workflows, and secure resilient service arrangements are better positioned to translate automation investments into measurable improvements in safety and efficiency.

In closing, the imperative is clear: treat automation not as an isolated capital purchase but as a strategic program that requires deliberate planning, stakeholder alignment, and continuous performance management. With this posture, healthcare organizations can harness the technical benefits of automated compounding while sustaining the clinical excellence and patient safety that underpin sterile preparation operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence for predictive maintenance and process optimization within sterile compounding workflows
  • 5.2. Expansion of robotic compounding systems with barcode verification to reduce human error and enhance patient safety measures
  • 5.3. Development of closed-system transfer devices integrated within pharmacy automation for hazardous drug handling compliance
  • 5.4. Adoption of cloud-based software platforms for remote monitoring and real-time data analytics of compounding operations
  • 5.5. Customizable dose preparation modules for high-risk chemotherapy and biologics with inline gravimetric verification
  • 5.6. Shift towards modular and scalable compounding units designed for point-of-care applications in hospital pharmacies
  • 5.7. Implementation of disposables and single-use sterile cassettes to streamline cleaning validation and reduce cross-contamination risks
  • 5.8. Collaboration between compounding device manufacturers and electronic health record vendors for seamless prescription to production workflows
  • 5.9. Growing regulatory scrutiny driving adoption of ISO 5 compliant compounding enclosures with automated environmental monitoring
  • 5.10. Emergence of decentralized compounding hubs leveraging networked automation to meet personalized medicine demand

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Automated Compounding Devices Market, by Type

  • 8.1. Peristaltic
  • 8.2. Piston Driven
  • 8.3. Volumetric

9. Automated Compounding Devices Market, by Application

  • 9.1. Analgesia
  • 9.2. Chemotherapy
    • 9.2.1. General Oncology
    • 9.2.2. Targeted Therapy
  • 9.3. Parenteral Nutrition
    • 9.3.1. Central Venous
    • 9.3.2. Peripheral Venous

10. Automated Compounding Devices Market, by End User

  • 10.1. Compounding Pharmacy
  • 10.2. Home Healthcare
  • 10.3. Hospital Pharmacy
    • 10.3.1. Large Hospital
    • 10.3.2. Small Hospital
  • 10.4. Retail Pharmacy

11. Automated Compounding Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. National Distributors
    • 11.2.2. Regional Distributors
  • 11.3. Online Sales

12. Automated Compounding Devices Market, by Software Type

  • 12.1. Integrated
  • 12.2. Standalone

13. Automated Compounding Devices Market, by Workflow Type

  • 13.1. Batch
  • 13.2. Continuous

14. Automated Compounding Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Automated Compounding Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Automated Compounding Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Baxter International Inc.
    • 17.3.2. Fresenius Kabi AG
    • 17.3.3. B. Braun Melsungen AG
    • 17.3.4. ICU Medical, Inc.
    • 17.3.5. Omnicell, Inc.
    • 17.3.6. Ivenix, Inc.
    • 17.3.7. Qcore Medical, Inc.
    • 17.3.8. Telstar S.A.
    • 17.3.9. Swisslog AG
    • 17.3.10. Capsa Healthcare, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. AUTOMATED COMPOUNDING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. AUTOMATED COMPOUNDING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. AUTOMATED COMPOUNDING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERISTALTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PISTON DRIVEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ANALGESIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY GENERAL ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TARGETED THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CENTRAL VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PERIPHERAL VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COMPOUNDING PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY LARGE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SMALL HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY INTEGRATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY STANDALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY SOFTWARE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY WORKFLOW TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY CHEMOTHERAPY, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST AUTOMATED COMPOUNDING DEVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST AUTOMATED COMPOU